Akers Biosciences, Inc. (AKER) has 7 open-market insider trades by 5 insiders since 2014. The most active filer is Hudson Bay Capital Management LP, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP via Sander Gerber | 10% Owner | — | 2 | $774K | 2020-02-27 |
| Gary M. Rauch | TreasurerVP - Finance | — | 2 | $8K | 2017-10-17 |
| John J. Gormally | CEO | — | 1 | $6K | 2017-10-17 |
| Raymond Francis Akers Jr. | ChairmanSecretary | — | 1 | $3K | 2016-01-05 |
| Sander Gerber | 10% | — | 1 | $2K | 2020-02-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Sander Gerber | 10% | Sell | $2K | 2020-02-28 |
| Hudson Bay Capital Management LP | 10% | Sell | $80K | 2020-02-25 |
| Hudson Bay Capital Management LP | 10% Owner | Buy | $695K | 2019-12-09 |
| John J. Gormally | CEO | Buy | $6K | 2016-05-24 |
| Raymond Francis Akers Jr. | Chairman & Secretary | Buy | $3K | 2016-01-05 |
| Gary M. Rauch | Treasurer & VP - Finance | Buy | $5K |
Companies that share insiders with AKER, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2015-12-11 |
| Gary M. Rauch | Treasurer & VP of Finance | Buy | $3K | 2014-08-22 |